![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CALCOCO2 |
Gene summary for CALCOCO2 |
![]() |
Gene information | Species | Human | Gene symbol | CALCOCO2 | Gene ID | 10241 |
Gene name | calcium binding and coiled-coil domain 2 | |
Gene Alias | NDP52 | |
Cytomap | 17q21.32 | |
Gene Type | protein-coding | GO ID | GO:0002376 | UniProtAcc | Q13137 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10241 | CALCOCO2 | S027 | Human | Liver | HCC | 2.62e-14 | 1.20e+00 | 0.2446 |
10241 | CALCOCO2 | S028 | Human | Liver | HCC | 7.73e-21 | 1.18e+00 | 0.2503 |
10241 | CALCOCO2 | S029 | Human | Liver | HCC | 2.45e-24 | 1.26e+00 | 0.2581 |
10241 | CALCOCO2 | C04 | Human | Oral cavity | OSCC | 3.83e-11 | 8.06e-01 | 0.2633 |
10241 | CALCOCO2 | C21 | Human | Oral cavity | OSCC | 6.21e-42 | 1.37e+00 | 0.2678 |
10241 | CALCOCO2 | C30 | Human | Oral cavity | OSCC | 1.22e-35 | 1.69e+00 | 0.3055 |
10241 | CALCOCO2 | C38 | Human | Oral cavity | OSCC | 2.11e-11 | 1.46e+00 | 0.172 |
10241 | CALCOCO2 | C43 | Human | Oral cavity | OSCC | 1.70e-16 | 4.47e-01 | 0.1704 |
10241 | CALCOCO2 | C46 | Human | Oral cavity | OSCC | 9.62e-20 | 6.72e-01 | 0.1673 |
10241 | CALCOCO2 | C51 | Human | Oral cavity | OSCC | 2.92e-03 | 5.22e-01 | 0.2674 |
10241 | CALCOCO2 | C57 | Human | Oral cavity | OSCC | 7.87e-08 | 4.47e-01 | 0.1679 |
10241 | CALCOCO2 | C08 | Human | Oral cavity | OSCC | 3.47e-25 | 6.24e-01 | 0.1919 |
10241 | CALCOCO2 | C09 | Human | Oral cavity | OSCC | 2.99e-03 | 1.45e-01 | 0.1431 |
10241 | CALCOCO2 | LN46 | Human | Oral cavity | OSCC | 2.19e-11 | 7.54e-01 | 0.1666 |
10241 | CALCOCO2 | EOLP-1 | Human | Oral cavity | EOLP | 1.07e-04 | 1.73e-01 | -0.0202 |
10241 | CALCOCO2 | NEOLP-3 | Human | Oral cavity | NEOLP | 7.68e-05 | 2.67e-01 | -0.0191 |
10241 | CALCOCO2 | SYSMH1 | Human | Oral cavity | OSCC | 9.06e-05 | 2.24e-01 | 0.1127 |
10241 | CALCOCO2 | SYSMH2 | Human | Oral cavity | OSCC | 1.36e-17 | 6.11e-01 | 0.2326 |
10241 | CALCOCO2 | SYSMH3 | Human | Oral cavity | OSCC | 1.25e-15 | 5.16e-01 | 0.2442 |
10241 | CALCOCO2 | SYSMH4 | Human | Oral cavity | OSCC | 1.02e-03 | 3.97e-02 | 0.1226 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0016032 | Colorectum | AD | viral process | 168/3918 | 415/18723 | 4.67e-20 | 3.66e-17 | 168 |
GO:0009896 | Colorectum | AD | positive regulation of catabolic process | 180/3918 | 492/18723 | 4.33e-16 | 1.94e-13 | 180 |
GO:0031331 | Colorectum | AD | positive regulation of cellular catabolic process | 156/3918 | 427/18723 | 4.68e-14 | 1.05e-11 | 156 |
GO:0022411 | Colorectum | AD | cellular component disassembly | 147/3918 | 443/18723 | 8.53e-10 | 6.76e-08 | 147 |
GO:0010506 | Colorectum | AD | regulation of autophagy | 111/3918 | 317/18723 | 3.57e-09 | 2.35e-07 | 111 |
GO:0016236 | Colorectum | AD | macroautophagy | 103/3918 | 291/18723 | 6.76e-09 | 4.15e-07 | 103 |
GO:0032984 | Colorectum | AD | protein-containing complex disassembly | 81/3918 | 224/18723 | 9.41e-08 | 4.65e-06 | 81 |
GO:0061912 | Colorectum | AD | selective autophagy | 29/3918 | 68/18723 | 4.20e-05 | 7.39e-04 | 29 |
GO:0016241 | Colorectum | AD | regulation of macroautophagy | 50/3918 | 141/18723 | 4.55e-05 | 7.92e-04 | 50 |
GO:0010508 | Colorectum | AD | positive regulation of autophagy | 43/3918 | 124/18723 | 2.64e-04 | 3.27e-03 | 43 |
GO:0043244 | Colorectum | AD | regulation of protein-containing complex disassembly | 41/3918 | 121/18723 | 6.22e-04 | 6.48e-03 | 41 |
GO:0043243 | Colorectum | AD | positive regulation of protein-containing complex disassembly | 14/3918 | 35/18723 | 7.92e-03 | 4.73e-02 | 14 |
GO:00160324 | Colorectum | FAP | viral process | 114/2622 | 415/18723 | 3.00e-13 | 2.63e-10 | 114 |
GO:00098964 | Colorectum | FAP | positive regulation of catabolic process | 126/2622 | 492/18723 | 3.76e-12 | 2.56e-09 | 126 |
GO:00313314 | Colorectum | FAP | positive regulation of cellular catabolic process | 110/2622 | 427/18723 | 6.09e-11 | 2.19e-08 | 110 |
GO:00105063 | Colorectum | FAP | regulation of autophagy | 80/2622 | 317/18723 | 6.43e-08 | 4.54e-06 | 80 |
GO:00162363 | Colorectum | FAP | macroautophagy | 70/2622 | 291/18723 | 2.73e-06 | 1.02e-04 | 70 |
GO:00224114 | Colorectum | FAP | cellular component disassembly | 97/2622 | 443/18723 | 3.44e-06 | 1.23e-04 | 97 |
GO:00329844 | Colorectum | FAP | protein-containing complex disassembly | 54/2622 | 224/18723 | 3.37e-05 | 7.48e-04 | 54 |
GO:00162413 | Colorectum | FAP | regulation of macroautophagy | 38/2622 | 141/18723 | 3.78e-05 | 8.13e-04 | 38 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa05131 | Colorectum | AD | Shigellosis | 109/2092 | 247/8465 | 1.09e-11 | 2.44e-10 | 1.55e-10 | 109 |
hsa04137 | Colorectum | AD | Mitophagy - animal | 29/2092 | 72/8465 | 2.49e-03 | 1.35e-02 | 8.59e-03 | 29 |
hsa051311 | Colorectum | AD | Shigellosis | 109/2092 | 247/8465 | 1.09e-11 | 2.44e-10 | 1.55e-10 | 109 |
hsa041371 | Colorectum | AD | Mitophagy - animal | 29/2092 | 72/8465 | 2.49e-03 | 1.35e-02 | 8.59e-03 | 29 |
hsa051318 | Colorectum | FAP | Shigellosis | 76/1404 | 247/8465 | 1.57e-08 | 5.84e-07 | 3.55e-07 | 76 |
hsa041378 | Colorectum | FAP | Mitophagy - animal | 20/1404 | 72/8465 | 1.14e-02 | 3.92e-02 | 2.38e-02 | 20 |
hsa051319 | Colorectum | FAP | Shigellosis | 76/1404 | 247/8465 | 1.57e-08 | 5.84e-07 | 3.55e-07 | 76 |
hsa041379 | Colorectum | FAP | Mitophagy - animal | 20/1404 | 72/8465 | 1.14e-02 | 3.92e-02 | 2.38e-02 | 20 |
hsa0513110 | Colorectum | CRC | Shigellosis | 59/1091 | 247/8465 | 1.19e-06 | 5.41e-05 | 3.66e-05 | 59 |
hsa0413710 | Colorectum | CRC | Mitophagy - animal | 17/1091 | 72/8465 | 8.74e-03 | 4.00e-02 | 2.71e-02 | 17 |
hsa0513111 | Colorectum | CRC | Shigellosis | 59/1091 | 247/8465 | 1.19e-06 | 5.41e-05 | 3.66e-05 | 59 |
hsa0413711 | Colorectum | CRC | Mitophagy - animal | 17/1091 | 72/8465 | 8.74e-03 | 4.00e-02 | 2.71e-02 | 17 |
hsa0513139 | Esophagus | HGIN | Shigellosis | 71/1383 | 247/8465 | 4.89e-07 | 7.98e-06 | 6.34e-06 | 71 |
hsa0413730 | Esophagus | HGIN | Mitophagy - animal | 23/1383 | 72/8465 | 7.69e-04 | 7.59e-03 | 6.03e-03 | 23 |
hsa0516420 | Esophagus | HGIN | Influenza A | 42/1383 | 171/8465 | 3.41e-03 | 2.54e-02 | 2.02e-02 | 42 |
hsa05131114 | Esophagus | HGIN | Shigellosis | 71/1383 | 247/8465 | 4.89e-07 | 7.98e-06 | 6.34e-06 | 71 |
hsa04137113 | Esophagus | HGIN | Mitophagy - animal | 23/1383 | 72/8465 | 7.69e-04 | 7.59e-03 | 6.03e-03 | 23 |
hsa05164110 | Esophagus | HGIN | Influenza A | 42/1383 | 171/8465 | 3.41e-03 | 2.54e-02 | 2.02e-02 | 42 |
hsa05131211 | Esophagus | ESCC | Shigellosis | 176/4205 | 247/8465 | 2.27e-12 | 4.01e-11 | 2.05e-11 | 176 |
hsa0516425 | Esophagus | ESCC | Influenza A | 122/4205 | 171/8465 | 5.01e-09 | 4.79e-08 | 2.45e-08 | 122 |
Page: 1 2 3 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CALCOCO2 | SNV | Missense_Mutation | c.742N>C | p.Glu248Gln | p.E248Q | Q13137 | protein_coding | tolerated(0.08) | benign(0.249) | TCGA-AN-A0XW-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
CALCOCO2 | SNV | Missense_Mutation | c.489N>C | p.Gln163His | p.Q163H | Q13137 | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-D8-A1JA-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | PD | |
CALCOCO2 | SNV | Missense_Mutation | c.712N>A | p.Glu238Lys | p.E238K | Q13137 | protein_coding | tolerated(0.08) | possibly_damaging(0.78) | TCGA-S3-AA14-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | CR | |
CALCOCO2 | SNV | Missense_Mutation | c.1073N>G | p.Glu358Gly | p.E358G | Q13137 | protein_coding | deleterious(0.02) | possibly_damaging(0.729) | TCGA-DR-A0ZM-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unspecific | Cisplatin | SD | |
CALCOCO2 | SNV | Missense_Mutation | c.25C>T | p.Pro9Ser | p.P9S | Q13137 | protein_coding | deleterious(0.01) | probably_damaging(0.928) | TCGA-AA-3692-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | folinic | PD | |
CALCOCO2 | SNV | Missense_Mutation | novel | c.840N>T | p.Glu280Asp | p.E280D | Q13137 | protein_coding | deleterious(0.04) | benign(0.281) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
CALCOCO2 | SNV | Missense_Mutation | rs769234486 | c.95N>G | p.Tyr32Cys | p.Y32C | Q13137 | protein_coding | deleterious(0.02) | possibly_damaging(0.5) | TCGA-AG-A01Y-01 | Colorectum | rectum adenocarcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | CR |
CALCOCO2 | SNV | Missense_Mutation | novel | c.912G>T | p.Lys304Asn | p.K304N | Q13137 | protein_coding | deleterious(0.04) | possibly_damaging(0.511) | TCGA-AJ-A2QO-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CALCOCO2 | SNV | Missense_Mutation | c.544G>A | p.Glu182Lys | p.E182K | Q13137 | protein_coding | tolerated(0.15) | benign(0.02) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
CALCOCO2 | SNV | Missense_Mutation | rs759040135 | c.1244C>T | p.Pro415Leu | p.P415L | Q13137 | protein_coding | tolerated(1) | benign(0) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |